Clinical Trials Logo

Clinical Trial Summary

To prospectively identify cancer patients whose tumors express specific molecular markers targeted by therapeutic agents from a comprehensive l i q u i d molecular test, for the purpose of selecting the most clinically appropriate treatment in a pragmatic two arm trial.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05703243
Study type Observational [Patient Registry]
Source Glendale Adventist Medical Center d/b/a Adventist Health Glendale
Contact Mihran H Shirinian, MD
Phone 818-543-7574
Email mshirin@aol.com
Status Recruiting
Phase
Start date February 1, 2023
Completion date January 1, 2025